维普期刊资源整合服务平台（V6.5）

62篇 您的检索式：作者名="Papapoulos SE"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Ueroxisome proliferator- activated receptor gamma(PPARgamma) as a molecular target for the soy phvtoestrogen genistein显示文摘	Dang ZC Audlnot V Papapoulos SE etal	2003	J Biol Chem2003，278，2：	1
2	Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro显示文摘	Van Bezooijen RL van der Wee-Pals L Papapoulos SE	2002	Ann Rheum Dis2002，61，：	1
3	IL-17 : Anew bone acting cytokine in Vitro显示文摘	Van bezooijen RL Farih-Sips HC Papapoulos SE	1999	J Bone Miner Res1999，14，9：	1
4	Scleros- tin: current knowledge and future perspectives显示文摘	Moester MJ Papapoulos SE Lowik CW	2010	Calcif Tissue Int2010，87，2：	1
5	Increased bone mass with pamidronate treatment in rheumatoid arthritis : Results of a threeyear randomized, double-blind trial 显示文摘	Eggelmeijer F Papapoulos SE van PH	1996	Arthritis Rheum1996，39，3：	1
6	Targeting sclerostin as potential treatment of osteoporosis显示文摘	Papapoulos SE	2011	Ann Rheum Dis2011，70，1：	1
7	Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women显示文摘	Papapoulos SE Quandt SA Liberman UA		0，，05：	1
8	Prolonged bisphosphonate release after treatment in children显示文摘	Papapoulos SE Cremers SC	2007	N Engl J Med2007，356，10：	1
9	Targeting sclerostin as potential treat ment of osteoporosis显示文摘	Papapoulos SE	2011	Ann Rheum Dis2011，70，：	1
10	The use of bisphosphonate in the treatment of osteoporosis显示文摘	Papapoulos SE Landman JO Bijvoet OL	1992	Bone1992，3，1：	1
11	Clinical risk factors as predictors of postmenopausal osteoporosis in general practice显示文摘	Versluis RG Papapoulos SE Zwinderman AH		0，，：	1
12	SOST/sclerostin,an osteocyte-derived negative regulator of bone formation显示文摘	van Bezooijen RL ten Dijke P Papapoulos SE		0，，：	1
13	Interleukin 17 synergises with tumour necrosis factor 'alpha to induce cartilage destruction in vitro显示文摘	Van Bezooijen RL van der Wee-pals L Papapoulos SE	2002	Ann Rheum Dis2002，61，10：	1
14	Sclerostin:Current knowledge and future perspectives显示文摘	Moester MJ Papapoulos SE L(o)wik CW		0，，02：	1
15	Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis:a double blind placebo controlled study显示文摘	Eggelmeijer F Papapoulos SE van Paassen HC	1994	J Rheumatol1994，21，11：	1
16	Bone diseases:Bisphosphonates in osteoporosis-beyond 5 years显示文摘	Papapoulos SE		0，，：	1
17	Sclerostin:current knowledge and future perspectives显示文摘	Moester MJ Papapoulos SE Lowik CW		0，，02：	1
18	Inter- leukin 17 synergises with tumour necrosis factor alpha to induce car- tilage destruction in vitro显示文摘	Van Bezooijen RL Van Der Wee-Pals L Papapoulos SE	2002	Ann Rheum Dis2002，61，10：	1
19	Meta analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women显示文摘	Papapoulos SE Quandt SA Liberman UA	2005	Osteoporos Int2005，16，2：	1
20	Skeletalretention of bisphosphonate (pamidronate) and its relation tothe rate of bone resorption in patients with breast cancer andbone metastases显示文摘	Cremers SC Papapoulos SE Gelderblom H	2005	J Bone Miner Res2005，20，9：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示